Wikidata

(Q41604120)

English

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

scientific article published on August 2005

In more languages

Statements

title
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
author name string
Michael von Wagner
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
Miriam Huber
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
Thomas Berg
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
Jens Rasenack
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
Christine Bernsmeier
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
Eva Herrmann
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
publication date
1 August 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017
page(s)
522-527
1 reference
stated in
Europe PubMed Central
PubMed ID
16083709
retrieved
4 October 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q41604120&oldid=2032501848"